DarioHealth Corp

DarioHealth Corp

DRIO - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$15.2M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
DarioHealth CorpDarioHealth Corp8.4-86%1.30.5
$6.00

Target Price by Analysts

376.2% upsideDarioHealth Target Price DetailsTarget Price
$-6.84

Current Fair Value

643% downside

Overvalued by 643% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$15.20 Million
Enterprise Value$20.57 Million
Earnings per Share$-0.81
Beta1.18
Outstanding Shares12,060,332

Return

Return on Equity85.60%ROE
Return on Assets54.26%
Return on Invested Capital-29.36%

Valuation & Multiples

P/E Ratio8.4P/E Ratio
PEG-5.72PEG
Price to Sales1.26Price to Sales
Price to Book Ratio0.25Price to Book Ratio
Enterprise Value to Revenue0.97
Enterprise Value to EBIT-0.68
Enterprise Value to Net Income0
Total Debt to Enterprise1.61
Debt to Equity0.47Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS
-$0.73
Est. -$0.95
Revenue
$5.31 M
Est. $5.21 M

Next Earnings Call

Expected Date
March 18, 2027
EPS Estimate
-$0.68
Consensus analyst estimate
Revenue Estimate
$5.54 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %13.30%▲ 4.13%
Total Invested$8.49M▲ 50.23%
Investors Holding14▼ 8.00%

About DarioHealth Corp

DarioHealth Insider Information FAQ

Stockcircle tracks 2 top investors with a current 13F position in DarioHealth. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider purchase for DarioHealth in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.